Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Schechter

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
JAMA|August 21, 1987
Discounting, isoniazid, and tuberculosisD N Rose, C B Schechter, A L Silver
Critical Care Medicine|October 6, 2001
Outcome prediction model for very elderly critically ill patientsD M Nierman, C B Schechter, L M Cannon, et al.
American Journal of Preventive Medicine|May 1, 1990
Tuberculin screening: cost-effectiveness analysis of various testing schedulesC B Schechter, D N Rose, M C Fahs, et al.
Preventive Medicine|March 1, 1997
BCG vaccination to prevent tuberculosis in health care workers: a decision analysisA M Marcus, D N Rose, H S Sacks, et al.
American Journal of Preventive Medicine|March 1, 1988
Tuberculosis prevention: cost-effectiveness analysis of isoniazid chemoprophylaxisD N Rose, C B Schechter, M C Fahs, et al.
Breast (Edinburgh, Scotland)|March 8, 2016
Reply to Koleva-Kolarova et alH J de Koning, O Alagoz, C B Schechter, et al.
The American Journal of Cardiology|June 30, 1998
Effects of practice setting on quality of lipid-lowering management in patients with coronary artery diseaseD J Harnick, J L Cohen, C B Schechter, et al.
Digestive Diseases and Sciences|May 9, 2001
Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: global and quantitative assessmentM C See, A H Birnbaum, C B Schechter, et al.
Diabetes Care|March 1, 1997
Effect of a bicultural community health worker on completion of diabetes education in a Hispanic populationE Corkery, C Palmer, M E Foley, et al.
The American Journal of Medicine|May 13, 1999
The utility of an in-hospital observation period after discontinuing intravenous antibioticsA S Dunn, K L Peterson, C B Schechter, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
JAMA|August 21, 1987
Discounting, isoniazid, and tuberculosisD N Rose, C B Schechter, A L Silver
Critical Care Medicine|October 6, 2001
Outcome prediction model for very elderly critically ill patientsD M Nierman, C B Schechter, L M Cannon, et al.
American Journal of Preventive Medicine|May 1, 1990
Tuberculin screening: cost-effectiveness analysis of various testing schedulesC B Schechter, D N Rose, M C Fahs, et al.
Preventive Medicine|March 1, 1997
BCG vaccination to prevent tuberculosis in health care workers: a decision analysisA M Marcus, D N Rose, H S Sacks, et al.
American Journal of Preventive Medicine|March 1, 1988
Tuberculosis prevention: cost-effectiveness analysis of isoniazid chemoprophylaxisD N Rose, C B Schechter, M C Fahs, et al.
Breast (Edinburgh, Scotland)|March 8, 2016
Reply to Koleva-Kolarova et alH J de Koning, O Alagoz, C B Schechter, et al.
The American Journal of Cardiology|June 30, 1998
Effects of practice setting on quality of lipid-lowering management in patients with coronary artery diseaseD J Harnick, J L Cohen, C B Schechter, et al.
Digestive Diseases and Sciences|May 9, 2001
Double-blind, placebo-controlled trial of famotidine in children with abdominal pain and dyspepsia: global and quantitative assessmentM C See, A H Birnbaum, C B Schechter, et al.
Diabetes Care|March 1, 1997
Effect of a bicultural community health worker on completion of diabetes education in a Hispanic populationE Corkery, C Palmer, M E Foley, et al.
The American Journal of Medicine|May 13, 1999
The utility of an in-hospital observation period after discontinuing intravenous antibioticsA S Dunn, K L Peterson, C B Schechter, et al.
Pageof 4